Performance of ABBV AbbVie | 19.7% in 12m

Compare ABBV with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare AbbVie with its related Sector/Index XBI

Compare AbbVie with its related Sector/Index XBI

Performance Duell ABBV vs XBI

TimeFrame ABBV XBI
1 Day 0.97% -0.02%
1 Week 2.59% -0.33%
1 Month 2.30% -6.54%
3 Months 18.8% 4.44%
6 Months 22.0% 28.65%
12 Months 19.7% 27.48%
YTD 15.0% 5.16%
Rel. Perf. 1m 0.76
Rel. Perf. 3m -0.64
Rel. Perf. 6m -0.68
Rel. Perf. 12m -0.50

Is AbbVie a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, AbbVie (NYSE:ABBV) is currently (March 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 3.84 and therefor a somewhat positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABBV as of March 2024 is 192.25. This means that ABBV is currently undervalued and has a potential upside of +5.57% (Margin of Safety).

Is ABBV a buy, sell or hold?

  • Strong Buy: 8
  • Buy: 9
  • Hold: 11
  • Sell: 0
  • Strong Sell: 0
AbbVie has received a consensus analysts rating of 3.89. Therefor, it is recommend to buy ABBV.
Values above 0%: ABBV is performing better - Values below 0%: ABBV is underperforming

Compare ABBV with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 2.42% -1.34% -0.98% -14.41%
US NASDAQ 100 QQQ 3.01% 0.16% -2.54% -25.81%
US Dow Jones Industrial 30 DIA 2.59% -0.04% 2.69% -5.49%
German DAX 40 DBXD 0.82% -2.78% 1.38% -1.72%
UK FTSE 100 ISFU 1.83% -2.63% 11.79% 6.74%
Shanghai Shenzhen CSI 300 CSI 300 4.47% 0.48% 26.39% 35.42%
Hongkong Hang Seng HSI 6.13% 7.02% 28.06% 40.28%
Japan Nikkei 225 EXX7 3.13% -1.25% 0.10% -8.58%
India NIFTY 50 INDA 0.49% 1.26% 5.37% -14.87%
Brasil Bovespa EWZ 2.99% 5.09% 11.75% -9.20%

ABBV AbbVie vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 2.58% -1.79% -2.52% -27.79%
Consumer Discretionary XLY 2.83% 1.69% 6.67% -11.05%
Consumer Staples XLP 2.13% -0.85% 9.65% 12.79%
Energy XLE 0.64% -8.73% 17.80% -1.19%
Financial XLF 2.06% -2.45% -4.94% -16.76%
Health Care XLV 1.15% 0.76% 7.15% 1.54%
Industrial XLI 2.34% -2.44% -2.69% -10.67%
Materials XLB 1.56% -4.98% 2.65% -2.20%
Real Estate XLRE 1.44% -0.27% 3.49% 3.65%
Technology XLK 3.34% 0.39% -6.02% -25.93%
Utilities XLU -0.36% -4.32% 8.39% 16.76%
Aerospace & Defense XAR 2.04% -0.36% -4.14% -3.61%
Biotech XBI 2.92% 8.84% -6.69% -7.75%
Homebuilder XHB 2.10% -7.00% -23.31% -51.59%
Retail XRT 1.50% -1.90% -9.60% -11.76%

ABBV AbbVie vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 0.10% -4.64% 25.44% -2.24%
Natural Gas UNG 7.49% 15.21% 68.71% 66.40%
Gold GLD 0.73% -6.93% 3.20% 7.58%
Silver SLV 2.15% -8.41% 12.27% 13.57%
Copper CPER 3.69% -2.94% 12.31% 18.72%

Returns of ABBV vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.95% 0.81% 13.18% 25.94%
iShares High Yield Corp. Bond HYG 2.65% 1.60% 13.39% 7.35%
Does AbbVie outperform its market, is ABBV a Sector Leader?
No, over the last 12 months AbbVie (ABBV) made 19.73%, while its related Sector, the SPDR S&P Biotech (XBI) made 27.48%.
Over the last 3 months ABBV made 18.80%, while XBI made 4.44%.
Period ABBV XBI S&P 500
1 Month 2.30% -6.54% 3.64%
3 Months 18.80% 4.44% 10.07%
12 Months 19.73% 27.48% 34.14%